Product Information
MILI 0.25-0.035 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1257 per EA under NDC 65862077685. Its NADAC has been published 412 times since Aug 8, 2018.
Manufacturer
Aurobindo Pharma LimitedNDC
65862077685
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205449On Market Since
7/7/2016
Price Statistics
The NADAC for MILI 0.25-0.035 MG TABLET has been published 412 times since Aug 8, 2018, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1257 per EA |
|---|---|
| All-time high | $0.2653 (Nov 14, 2018) |
| All-time low | $0.1011 (Nov 20, 2024) |
| 52-week high | $0.1351 |
| 52-week low | $0.1230 |
| Median price | $0.1546 |
| Average price | $0.1766 |
| Largest weekly change | -21.9% (Nov 20, 2024) |
| Weeks tracked | 412 |
| Tracking since | Aug 8, 2018 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 17% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MILI 0.25-0.035 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MILI 0.25-0.035 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1257 per EA (NDC 65862077685), effective Jun 24, 2026.
How has the price of MILI 0.25-0.035 MG TABLET changed over time?
Over the history we have for it, the NADAC for MILI 0.25-0.035 MG TABLET has declined 51.6%. It has been tracked across 412 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for MILI 0.25-0.035 MG TABLET?
Since Aug 8, 2018, the NADAC for MILI 0.25-0.035 MG TABLET has ranged from a low of $0.1011 (Nov 20, 2024) to a high of $0.2653 (Nov 14, 2018), with a median of $0.1546 per EA.
Are there cheaper alternatives to MILI 0.25-0.035 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TRI-LO-ESTARYLLA TABLET, is $0.1049 per EA — about 17% below MILI 0.25-0.035 MG TABLET.
Who manufactures MILI 0.25-0.035 MG TABLET?
MILI 0.25-0.035 MG TABLET (NDC 65862077685) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification